LEADER 02720nam  2200625Ia 450 
001 9910453994203321
005 20200520144314.0
010   $a1-282-00804-8
010   $a9786612008047
010   $a0-309-12868-4
035   $a(CKB)1000000000755462
035   $a(EBL)3378456
035   $a(SSID)ssj0000206354
035   $a(PQKBManifestationID)11187299
035   $a(PQKBTitleCode)TC0000206354
035   $a(PQKBWorkID)10214335
035   $a(PQKB)10505895
035   $a(MiAaPQ)EBC3378456
035   $a(Au-PeEL)EBL3378456
035   $a(CaPaEBR)ebr10280005
035   $a(CaONFJC)MIL200804
035   $a(OCoLC)923279910
035   $a(EXLCZ)991000000000755462
100   $a20090223d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMulti-center phase III clinical trials and NCI cooperative groups$b[electronic resource] $eworkshop summary /$fMargie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$d2009
215   $a1 online resource (135 p.)
300   $aDescription based upon print version of record.
311   $a0-309-12867-6 
320   $aIncludes bibliographical references (p. 97-101).
327   $a""Reviewers""; ""Contents""; ""Introduction""; ""Session 1A: Organization of the NCI Clinical Trials System""; ""Session 1B: Lessons from Non-Cooperative Group Multi-Center Clinical Trials""; ""Session 2: Barriers to Patient Recruitment and Physician Participation""; ""Session 3: Data Collection Standards and Monitoring""; ""Session 4: Costs of Cooperative Group Clinical Trials""; ""Summary and Wrap-Up""; ""References""; ""Abbreviations and Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Workshop Speakers""
327   $a""Appendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum""
606   $aCancer$xTreatment$zUnited States
606   $aClinical trials
608   $aElectronic books.
615  0$aCancer$xTreatment
615  0$aClinical trials.
676   $a610.724
701   $aPatlak$b Margie$0870815
701   $aNass$b Sharyl J$0857626
701   $aMicheel$b Christine$0870814
712 02$aNational Cancer Policy Forum (U.S.)
712 02$aInstitute of Medicine (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910453994203321
996   $aMulti-center phase III clinical trials and NCI cooperative groups$92453996
997   $aUNINA